| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab7070bd035f7ecb8a15826753799cc6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-14 |
| filingDate |
2010-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_966a97629205fde8357a102b3a76fdf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f054bb39f2c35a7cbdc2bf94b869bb96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b86d1cd40bd51d5d936cec674089f1 |
| publicationDate |
2015-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2537385-T3 |
| titleOfInvention |
Topical supply systems for ophthalmic use |
| abstract |
An aqueous ophthalmic solution comprising nanomyceles in a physiologically acceptable buffer, having a pH of 5.0 to 8.0, wherein dexamethasone in a concentration in the range of about 0.1% w / w to about 1.00% w / v is solubilized through entrapment in a mixed micellar hydrophobic core with a crown composed of hydrophilic chains that extend from the hydrophobic core where nanomyceles comprise vitamin E polyethylene glycol succinate tocopherol (TPGS) at a concentration in the range of approximately 2.0% w / w approximately 5.0% w / v stabilized with octoxynol-40 at a concentration in the range of about 1.0% w / w about 3.0% w / v. |
| priorityDate |
2009-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |